Shree Ganesh Biotech (India) Ltd — Others, 25-08-2025: Others

Shree Ganesh Bio-Tech has announced its Annual General Meeting to consider the financial results for the year ended March 31, 2025. The company reported revenue from operations of Rs 22.96 Cr, up from Rs 20.28 Cr, while net profit after tax stood at Rs 0.28 Cr, down from Rs 0.62 Cr. Shareholders will also vote on proposals to significantly increase borrowing limits and investment, loan, and guarantee limits, both up to Rs 100 Cr, to support future growth. The company, in hybrid seeds, aims to address working capital challenges and pursue new opportunities. No dividend was proposed.